WASHINGTON (AP) — Makers of medical tests that have long escaped government oversight will have about four years to show that their new offerings deliver accurate results, under a government rule vigorously opposed by the testing industry.
The regulation finalized Monday by the Food and Drug Administration will gradually phase in oversight of new tests developed by laboratories, a multibillion-dollar industry that regulators say poses growing risks to Americans. The goal is to ensure that new tests for cancer, heart disease, COVID-19, genetic conditions and many other illnesses are safe, accurate and reliable.
“The final rule announced today aims to provide crucial oversight of these tests to help ensure that important health care decisions are made based on test results that patients and health care providers can trust,” said FDA commissioner Robert Califf, in a release.
Related articles:
Related suggestion:
Olivia Williams opens up on 'harrowing' experience as guest star on season four finale of FriendsMore homes flooded in Russian region bordering Kazakhstan, other areasXi's article on cultural heritage, fine traditional Chinese culture to be publishedChina reveals cases highlighting ecological security threatsUS hypes up 'Volt Typhoon' false narrative to smear ChinaChina exercises veto power in UN Security Council to uphold international justice: envoyUS Olympic committee strikes sponsorship deal to help athletes get degrees after they retireChina's science foundation funds 31 bln yuan in research in 2023Hamas says 19 killed in Israeli shelling near Gaza City, Israel deniesChina to carry out third residents' time use survey
2.2419s , 6514.9375 kb
Copyright © 2024 Powered by FDA brings lab tests under federal oversight in bid to improve accuracy and safety ,Stellar Scope news portal